{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:16:24Z","timestamp":1790943384599,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.jns.2007.11.012","type":"journal-article","created":{"date-parts":[[2008,1,2]],"date-time":"2008-01-02T22:32:33Z","timestamp":1199313153000},"page":"87-94","source":"Crossref","is-referenced-by-count":52,"title":["The effect of hydroxyurea in spinal muscular atrophy cells and patients"],"prefix":"10.1016","volume":"268","author":[{"given":"Wen-Chen","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Yee","family":"Yuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Gowth","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Fu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Huei","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyh-Shin","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuh-Jyh","family":"Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2007.11.012_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jmg.15.6.409","article-title":"Incidence, prevelance and gene frequency studies of chronic childhood spinal muscular atrophy","volume":"15","author":"Pearn","year":"1978","journal-title":"J Med Genet"},{"key":"10.1016\/j.jns.2007.11.012_bib2","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/515465","article-title":"Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number","volume":"60","author":"McAndrew","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jns.2007.11.012_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2008-1040858","article-title":"Spinal muscular atrophy","volume":"18","author":"Iannaccone","year":"1998","journal-title":"Semin Neurol"},{"key":"10.1016\/j.jns.2007.11.012_bib4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1023\/A:1005516625866","article-title":"Spinal muscular atrophy","volume":"22","author":"Talbot","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jns.2007.11.012_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jns.2007.11.012_bib6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0959-437X(02)00301-5","article-title":"The molecular bases of spinal muscular atrophy","volume":"12","author":"Frugier","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.jns.2007.11.012_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/14737159.4.1.15","article-title":"Spinal muscular atrophy: molecular genetics and diagnostics","volume":"4","author":"Ogino","year":"2004","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jns.2007.11.012_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-510X(01)00574-3","article-title":"Molecular analysis of SMN, NAIP and P44 genes of SMA patients and their families","volume":"190","author":"Tsai","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2007.11.012_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/sj.ejhg.5201102","article-title":"Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy","volume":"12","author":"Andreassi","year":"2004","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jns.2007.11.012_bib10","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy","volume":"96","author":"Lorson","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.jns.2007.11.012_bib11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng854","article-title":"Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1","volume":"30","author":"Cartegni","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jns.2007.11.012_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1086\/498853","article-title":"Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2","volume":"78","author":"Cartegni","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jns.2007.11.012_bib13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/ng1207","article-title":"A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy","volume":"34","author":"Kashima","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jns.2007.11.012_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy","volume":"16","author":"Lefebvre","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.jns.2007.11.012_bib15","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/hmg\/6.8.1205","article-title":"The survival motor neuron protein in spinal muscular atrophy","volume":"6","author":"Coovert","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2007.11.012_bib16","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0092-8674(00)80367-0","article-title":"The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins","volume":"90","author":"Liu","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jns.2007.11.012_bib17","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1074\/jbc.M512243200","article-title":"Gemin 8 is a novel component of the survival motor neuron complex and functions in small nuclear ribonucleoprotein assembly","volume":"281","author":"Carissimi","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2007.11.012_bib18","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1126\/science.1074962","article-title":"Essential role for the SMN complex in the specificity of snRNP assembly","volume":"298","author":"Pellizzoni","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jns.2007.11.012_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yexcr.2004.03.022","article-title":"The SMN complex","volume":"296","author":"Gubitz","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jns.2007.11.012_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/71709","article-title":"A mouse model for spinal muscular atrophy","volume":"24","author":"Hsieh-Li","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.jns.2007.11.012_bib21","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1073\/pnas.171105098","article-title":"Treatment of spinal muscular atrophy by sodium butyrate","volume":"98","author":"Chang","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.jns.2007.11.012_bib22","first-page":"132","article-title":"Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols","volume":"23","author":"Berk","year":"1986","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jns.2007.11.012_bib23","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1182\/blood.V88.6.1960.bloodjournal8861960","article-title":"Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial","volume":"88","author":"Ferster","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jns.2007.11.012_bib24","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1182\/blood.V91.12.4472","article-title":"Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease","volume":"91","author":"Maier-Redelsperger","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jns.2007.11.012_bib25","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood-2003-07-2475","article-title":"Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease","volume":"103","author":"Zimmerman","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jns.2007.11.012_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<148::AID-AJH12>3.0.CO;2-I","article-title":"Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature","volume":"60","author":"Diav-Citrin","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jns.2007.11.012_bib27","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood-2004-12-4973","article-title":"Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study","volume":"106","author":"Hankins","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jns.2007.11.012_bib28","first-page":"57","article-title":"Hydroxyurea (NSC-32065) in biologic fluids: dose\u2013concentration relationship","volume":"48","author":"Beckloff","year":"1965","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.jns.2007.11.012_bib29","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1073\/pnas.95.11.6492","article-title":"Heterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissues","volume":"95","author":"Francis","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jns.2007.11.012_bib30","first-page":"241","article-title":"Evaluation of muscle strength in patients with spinal muscular atrophy","volume":"18","author":"Wang","year":"2002","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jns.2007.11.012_bib31","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0003-9993(23)00009-6","article-title":"Serial manual muscle testing in Duchenne muscular dystrophy","volume":"74","author":"Kilmer","year":"1993","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jns.2007.11.012_bib32","doi-asserted-by":"crossref","unstructured":"Carter GT, Abresch RT, Fowler WM Jr, Johnson ER, Kilmer DD, McDonald CM. Profiles of neuromuscular diseases: spinal muscular atrophy. Am J Phys Med Rehabil 1995; 74:S150\u22129.","DOI":"10.1097\/00002060-199509001-00009"},{"key":"10.1016\/j.jns.2007.11.012_bib33","unstructured":"Chang JG, Jong YJ, Tsai FJ. Hydroxyurea treatment for spinal muscular atrophy. 2003, US patent 6,573,300."},{"key":"10.1016\/j.jns.2007.11.012_bib34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ana.20548","article-title":"Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells","volume":"58","author":"Grzeschik","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2007.11.012_bib35","first-page":"1559","article-title":"Inhibition of ribonucleoside diphosphate reductase by hydroxyurea","volume":"28","author":"Krakoff","year":"1968","journal-title":"Cancer Res"},{"key":"10.1016\/j.jns.2007.11.012_bib36","first-page":"627","article-title":"Neuronal differentiation triggered by blocking cell proliferation","volume":"3","author":"LoPresti","year":"1992","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.jns.2007.11.012_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/blood.V69.1.109.109","article-title":"Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia","volume":"69","author":"Charache","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.jns.2007.11.012_bib38","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1056\/NEJM199004123221504","article-title":"Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea","volume":"322","author":"Rodgers","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2007.11.012_bib39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.1995.tb05584.x","article-title":"Hydroxyurea therapy in beta-thalassaemia intermedia: improvement in haematological parameters due to enhanced beta-globin synthesis","volume":"90","author":"Zeng","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jns.2007.11.012_bib40","first-page":"663","article-title":"The superfamily of arginine\/serine-rich splicing factors","volume":"1","author":"Fu","year":"1995","journal-title":"RNA"},{"key":"10.1016\/j.jns.2007.11.012_bib41","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1101\/gad.10.13.1569","article-title":"SR proteins and splicing control","volume":"10","author":"Manley","year":"1996","journal-title":"Gene Dev"},{"key":"10.1016\/j.jns.2007.11.012_bib42","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/hmg\/11.5.577","article-title":"SRp30c-dependent stimulation of survival motor neuron (SMN) exon 7 inclusion is facilitated by a direct interaction with hTra2 beta 1","volume":"11","author":"Young","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2007.11.012_bib43","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-510X(01)00632-3","article-title":"A placebo-controlled trial of gabapentin in spinal muscular atrophy","volume":"191","author":"Miller","year":"2001","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2007.11.012_bib44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.59.4.609","article-title":"Pilot trial of albuterol in spinal muscular atrophy","volume":"59","author":"Kinali","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2007.11.012_bib45","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nmd.2003.11.006","article-title":"Pilot trial of phenylbutyrate in spinal muscular atrophy","volume":"14","author":"Mercuri","year":"2004","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.jns.2007.11.012_bib46","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.ejhg.5201320","article-title":"Phenylbutyrate increases SMN gene expression in spinal muscular atrophy patients","volume":"13","author":"Brahe","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jns.2007.11.012_bib47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1212\/01.wnl.0000249142.82285.d6","article-title":"Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy","volume":"68","author":"Mercuri","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2007.11.012_bib48","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1001\/archneur.60.11.1601","article-title":"A phase I trial of riluzole in spinal muscular atrophy","volume":"60","author":"Russman","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2007.11.012_bib49","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells","volume":"54","author":"Sumner","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2007.11.012_bib50","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy","volume":"12","author":"Brichta","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jns.2007.11.012_bib51","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ana.20836","article-title":"In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate","volume":"59","author":"Brichta","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2007.11.012_bib52","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/hmg\/10.24.2841","article-title":"Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients","volume":"10","author":"Andreassi","year":"2001","journal-title":"Hum Mol Genet"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X07007368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X07007368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T16:40:47Z","timestamp":1684168847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X07007368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":52,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0022510X07007368"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2007.11.012","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}